Profile
Michael L.
Meyers is Vice President at Janssen Research & Development LLC.
Former roles include Independent Director at Nuvalent, Inc. from 2022 to 2026, Vice President-GU Oncology & Compound at Johnson & Johnson, Chief Medical Officer & Senior Vice President at Syndax Pharmaceuticals, Inc. from 2016 to 2022, Member at Memorial Sloan Kettering Cancer Center, Vice President-Oncology Scientific Innovation at Johnson & Johnson Innovation LLC, and Chief Medical Officer at Flare Therapeutics, Inc. from 2023 to 2026.
Education includes a doctorate from Albert Einstein College of Medicine, Inc.
Michael Meyers active positions
| Companies | Position | Start |
|---|---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | - |
Former positions of Michael Meyers
| Companies | Position | End |
|---|---|---|
| NUVALENT, INC. | Director/Board Member | 2026-07-14 |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Chief Tech/Sci/R&D Officer | 2026-01-30 |
| SYNDAX PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-02-28 |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | - |
Johnson & Johnson Innovation LLC
Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Provides healthcare solutions and services | Corporate Officer/Principal | - |
Training of Michael Meyers
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Johnson & Johnson Innovation LLC
Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Provides healthcare solutions and services | Health Services |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
- Stock Market
- Insiders
- Michael Meyers
















